Literature DB >> 27788932

Causes and Predictors of Death in Patients With Coronary Heart Disease (from the Heart and Soul Study).

Elizabeth Y Wang1, Jeffrey Dixson2, Nelson B Schiller3, Mary A Whooley3.   

Abstract

Although the prevalence of coronary heart disease (CHD) in the United States has increased during the past 25 years, cardiovascular mortality has decreased due to advances in CHD therapy and prevention. We sought to determine the proportion of patients with CHD who die from cardiovascular versus noncardiovascular causes and the causes and predictors of death, in a cohort of patients with CHD. The Heart and Soul Study enrolled 1,024 participants with stable CHD from 2000 to 2002 and followed them for 10 years. Causes of mortality were assigned based on detailed review of medical records, death certificates, and coroner reports by blinded adjudicators. During 7,680 person-years of follow-up, 401 participants died. Of these deaths, 42.4% were cardiovascular and 54.4% were noncardiovascular. Myocardial infarction, stroke, and sudden death accounted for 72% of cardiovascular deaths. Cancer, pneumonia, and sepsis accounted for 67% of noncardiovascular deaths. Independent predictors of cardiac mortality were older age, inducible ischemia on stress echocardiography, higher heart rate at rest, smoking, lower hemoglobin, and higher N-terminal pro-brain natriuretic peptide (all p values <0.05); independent predictors of noncardiac mortality included older age, inducible ischemia, higher heart rate, lower exercise capacity, and nonuse of statins (all p values <0.05). In conclusion, mortality in this cohort was more frequently due to noncardiovascular causes, and predictors of noncardiovascular mortality included factors traditionally associated with cardiovascular mortality. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27788932     DOI: 10.1016/j.amjcard.2016.09.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

2.  Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.

Authors:  Ruicong Ma; Jianbo Gao; Shiyuan Mao; Zhirong Wang
Journal:  Clin Cardiol       Date:  2022-03-30       Impact factor: 3.287

3.  Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial.

Authors:  Mandeep S Sidhu; Karen P Alexander; Zhen Huang; Sean M O'Brien; Bernard R Chaitman; Gregg W Stone; Jonathan D Newman; William E Boden; Aldo P Maggioni; Philippe Gabriel Steg; Thomas B Ferguson; Marcin Demkow; Jesus Peteiro; Gurpreet S Wander; Denis C Phaneuf; Mark A De Belder; Rolf Doerr; Erick Alexanderson-Rosas; Carisi A Polanczyk; Peter A Henriksen; Dwayne S G Conway; Vicente Miro; Tali Sharir; Renato D Lopes; James K Min; Daniel S Berman; Frank W Rockhold; Stephen Balter; David Borrego; Yves D Rosenberg; Sripal Bangalore; Harmony R Reynolds; Judith S Hochman; David J Maron
Journal:  Am Heart J       Date:  2022-02-09       Impact factor: 5.099

4.  Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.

Authors:  Tao Li; Weina Yao
Journal:  Exp Ther Med       Date:  2018-08-30       Impact factor: 2.447

Review 5.  Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease.

Authors:  Adam Timmis; Antony Raharja; R Andrew Archbold; Anthony Mathur
Journal:  Heart       Date:  2018-06-06       Impact factor: 5.994

6.  Cardiovascular outcomes related to social defeat stress: New insights from resilient and susceptible rats.

Authors:  Gessynger Morais-Silva; Willian Costa-Ferreira; Lucas Gomes-de-Souza; Jacqueline C Pavan; Carlos C Crestani; Marcelo T Marin
Journal:  Neurobiol Stress       Date:  2019-06-06

7.  Clinical study of chlamydia pneumoniae infection in patients with coronary heart disease.

Authors:  Lei Xue; Yan-Hong Liang; Yuan-Yuan Gao; Xiao-Juan Wang
Journal:  BMC Cardiovasc Disord       Date:  2019-05-14       Impact factor: 2.298

Review 8.  Experimental Rodent Models of Cardiovascular Diseases.

Authors:  Tian Jia; Chen Wang; Zhengxi Han; Xiaozhi Wang; Ming Ding; Quanyi Wang
Journal:  Front Cardiovasc Med       Date:  2020-12-07

9.  Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators.

Authors:  Hongtao Liu; Xinhai Jiang; Xinfeng Gao; Wenhua Tian; Chen Xu; Ruizhi Wang; Yanni Xu; Liping Wei; Feng Cao; Wenyan Li
Journal:  RSC Med Chem       Date:  2020-03-11

10.  Effect of Coronary Revascularization on the Prognostic Value of Stress Myocardial Contrast Wall Motion and Perfusion Imaging.

Authors:  Nicola Gaibazzi; Thomas Porter; Valentina Lorenzoni; Gianluca Pontone; Delia De Santis; Andrea De Rosa; Andrea Igoren Guaricci
Journal:  J Am Heart Assoc       Date:  2017-05-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.